- Home
- ASND vs CLS Comparison
ASND vs CLS Comparison
Compare ASND & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- CLS
- Stock Information
- Founded
- ASND 2006
- CLS 1994
- Country
- ASND Denmark
- CLS Canada
- Employees
- ASND N/A
- CLS N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- CLS Electrical Products
- Sector
- ASND Health Care
- CLS Technology
- Exchange
- ASND Nasdaq
- CLS Nasdaq
- Market Cap
- ASND 10.6B
- CLS 9.7B
- IPO Year
- ASND 2015
- CLS 1998
- Fundamental
- Price
- ASND $195.58
- CLS $241.72
- Analyst Decision
- ASND Strong Buy
- CLS Strong Buy
- Analyst Count
- ASND 16
- CLS 10
- Target Price
- ASND $240.75
- CLS $190.70
- AVG Volume (30 Days)
- ASND 418.2K
- CLS 3.2M
- Earning Date
- ASND 11-13-2025
- CLS 10-22-2025
- Dividend Yield
- ASND N/A
- CLS N/A
- EPS Growth
- ASND N/A
- CLS 55.91
- EPS
- ASND N/A
- CLS 4.59
- Revenue
- ASND $576,332,355.00
- CLS $10,587,200,000.00
- Revenue This Year
- ASND $101.37
- CLS $20.60
- Revenue Next Year
- ASND $76.17
- CLS $17.11
- P/E Ratio
- ASND N/A
- CLS $51.57
- Revenue Growth
- ASND 54.50
- CLS 20.52
- 52 Week Low
- ASND $111.09
- CLS $44.46
- 52 Week High
- ASND $208.16
- CLS $257.40
- Technical
- Relative Strength Index (RSI)
- ASND 52.37
- CLS 66.53
- Support Level
- ASND $196.06
- CLS $239.02
- Resistance Level
- ASND $202.57
- CLS $254.00
- Average True Range (ATR)
- ASND 6.49
- CLS 11.90
- MACD
- ASND -0.82
- CLS 3.36
- Stochastic Oscillator
- ASND 34.34
- CLS 78.74
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.